Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3385222rdf:typepubmed:Citationlld:pubmed
pubmed-article:3385222lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:3385222lifeskim:mentionsumls-concept:C0596790lld:lifeskim
pubmed-article:3385222lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:3385222lifeskim:mentionsumls-concept:C0205322lld:lifeskim
pubmed-article:3385222pubmed:issue3lld:pubmed
pubmed-article:3385222pubmed:dateCreated1988-7-29lld:pubmed
pubmed-article:3385222pubmed:abstractTextBetween 1984 and 1986, 31 sites in 27 patients with biopsy proven tumours were treated with a combination of interstitial microwave hyperthermia (HT) and iridium 192 implants (RT). The 31 sites treated included fifteen (48 per cent) head and neck, six (20 per cent) breast, four (13 per cent) vagina and cervix, and six (20 per cent) others. All patients had prior surgery, RT, or chemotherapy. Of the 31 sites treated, 19 (61 per cent) had complete response (CR) with no recurrence in the volume treated. Additionally, eight patients remained free of tumour from 3 to 24 months. Partial response (PR) was seen in 11 (36 per cent) sites while one (3 per cent) had lesser degree tumour regression. Tumour control rate correlated well with the dose of radiation, p = 0.02, and tumour volume, p = 0.02, but not with thermal dose. Treatment complications of significance occurred in one (3 per cent) site, which developed soft tissue necrosis. This study again has demonstrated the effectiveness of RT-HT combination in treatment of recurrent tumours.lld:pubmed
pubmed-article:3385222pubmed:languageenglld:pubmed
pubmed-article:3385222pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3385222pubmed:citationSubsetIMlld:pubmed
pubmed-article:3385222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3385222pubmed:statusMEDLINElld:pubmed
pubmed-article:3385222pubmed:issn0265-6736lld:pubmed
pubmed-article:3385222pubmed:authorpubmed-author:CohenDDlld:pubmed
pubmed-article:3385222pubmed:authorpubmed-author:LuxtonGGlld:pubmed
pubmed-article:3385222pubmed:authorpubmed-author:PetrovichZZlld:pubmed
pubmed-article:3385222pubmed:authorpubmed-author:LalDDlld:pubmed
pubmed-article:3385222pubmed:authorpubmed-author:LangholzBBlld:pubmed
pubmed-article:3385222pubmed:authorpubmed-author:AstrahanMMlld:pubmed
pubmed-article:3385222pubmed:authorpubmed-author:JepsonJJlld:pubmed
pubmed-article:3385222pubmed:issnTypePrintlld:pubmed
pubmed-article:3385222pubmed:volume4lld:pubmed
pubmed-article:3385222pubmed:ownerNLMlld:pubmed
pubmed-article:3385222pubmed:authorsCompleteYlld:pubmed
pubmed-article:3385222pubmed:pagination259-66lld:pubmed
pubmed-article:3385222pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:meshHeadingpubmed-meshheading:3385222-...lld:pubmed
pubmed-article:3385222pubmed:articleTitleInterstitial thermoradiotherapy for recurrent or persistent tumours.lld:pubmed
pubmed-article:3385222pubmed:affiliationDepartment of Radiation Oncology, University of Southern California School of Medicine, Los Angeles 90033.lld:pubmed
pubmed-article:3385222pubmed:publicationTypeJournal Articlelld:pubmed